Confronting blaNDM-5 in Salmonella Typhi: From Molecular Epidemiology, Resistance Mechanism to Clinical Management
Infection and Drug Resistance · 2026-04 · Volume 19 · 1-16
DOI: 10.2147/idr.s581658 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Infection and Drug Resistance, 2026-04. Verfasst von Xiaolan Guo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory, Shenshan Medical Centre, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Shanwei, Guangdong, People's Republic of China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
The emergence of Carbapenem-Resistant Salmonella enterica serovar Typhi (CR Salmonella enterica var typhi) represents a critical challenge in the prevention and control of typhoid fever. In recent years, CR Salmonella enterica var typhi strains carrying the bla NDM-5 gene have rapidly disseminated worldwide, particularly across South Asia such as India and Pakistan, severely exacerbating the clinical treatment failure rates and significant mortality. Due to the acceleration of global travel and trade, the multidrug resistant clones mainly transmitted through plasmids (such as lncX3), increasingly endanger China with historically low resistance levels. The CR Salmonella enterica var typhi strains exhibit extensive resistance to fluoroquinolones, cephalosporins, and carbapenems, compromising the effectiveness of conventional treatment regimens. Herein, efforts are made to provide a comprehensive review on the global epidemiology, underlying resistance mechanisms, the evolving challenges in clinical management. The antimicrobial resistance surveillance systems, such as whole-genome sequencing (WGS) technology, strict antibiotic management, infection control measures, and future perspectives on the combination therapies (such as meropenem combined with polymyxin) have also been discussed and outlooked. It is highly anticipated that the surveillance technologies combined with potential therapeutic pathways will witness a leap-forward development in clinical translation for public health.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Laboratory, Shenshan Medical Centre, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Shanwei, Guangdong, People's Republic of China.
ORCID-Profile: Xiaolan Guo
Zitieren
APA
Guo, X., Wu, J., & Li, K. (2026). Confronting blaNDM-5 in Salmonella Typhi: From Molecular Epidemiology, Resistance Mechanism to Clinical Management. Infection and Drug Resistance, Volume 19, 1-16. https://doi.org/10.2147/idr.s581658
Vancouver
Guo X, Wu J, Li K. Confronting blaNDM-5 in Salmonella Typhi: From Molecular Epidemiology, Resistance Mechanism to Clinical Management. Infection and Drug Resistance. 2026;Volume 19:1-16. doi:10.2147/idr.s581658
BibTeX
@article{Guo2026,
author = {Guo, Xiaolan and Wu, Jia and Li, Ke},
title = {Confronting blaNDM-5 in Salmonella Typhi: From Molecular Epidemiology, Resistance Mechanism to Clinical Management},
journal = {Infection and Drug Resistance},
year = {2026},
volume = {Volume 19},
pages = {1--16},
doi = {10.2147/idr.s581658}
}
EUVIMED